Alnylam Pharmaceuticals, Inc. (ALNY) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ALNYAlnylam Pharmaceuticals, Inc.Follow ALNY — free
—
Price chart with a free account
- Market cap
- 30.0B
- P/E TTM
- 41.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2010 Dec 10 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 97.6% | 88.6% | 84.9% | 86.4% | 86.5% | 85.3% | 86.4% | 81.8% | 79.8% | |
| Operating margin | -44.1% | -1087.6% | -427.5% | -168.1% | -83.9% | -75.7% | -15.4% | -7.9% | 13.5% | 20.8% | |
| Net margin | -43.5% | -1016.6% | -403.2% | -174.1% | -101.0% | -109.0% | -24.1% | -12.4% | 8.4% | — | |
| FCF margin | -89.0% | -920.5% | -190.5% | -139.1% | -85.0% | -59.1% | 2.3% | -1.9% | 12.5% | 17.1% |
USD billions · SEC XBRL
Alnylam Pharmaceuticals, Inc. — questions
- What is Alnylam Pharmaceuticals, Inc.'s gross margin?
- 79.8% over the twelve months to 2026-06-30.
- What is Alnylam Pharmaceuticals, Inc.'s operating margin?
- 20.8% over the twelve months to 2026-06-30.
Every figure on this page comes from Alnylam Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.